These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 1698137)
21. Gastric inhibitory polypeptide in obesity and diabetes mellitus. Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812 [TBL] [Abstract][Full Text] [Related]
22. Effects of a gastric partitioning operation for morbid obesity on the secretion of gastric inhibitory polypeptide and pancreatic polypeptide. Amland PF; Jorde R; Kildebo S; Burhol PG; Giercksky KE Scand J Gastroenterol; 1984 Sep; 19(6):857-61. PubMed ID: 6393318 [TBL] [Abstract][Full Text] [Related]
23. [The effect of selective proximal vagotomy on gastrin, GIP and insulin blood levels in patients with duodenal ulcer]. Börger HW; Schafmayer A; Becker HD Chir Forum Exp Klin Forsch; 1978; (1978):25-9. PubMed ID: 752595 [TBL] [Abstract][Full Text] [Related]
24. Use of diethylaminoethyl-dextran (DEAE-D) in the management of obesity: effect on insulin secretion. Vita F; Di Luigi L; Tofini G; Isidori A Int J Obes; 1987; 11 Suppl 3():215-20. PubMed ID: 2450072 [No Abstract] [Full Text] [Related]
25. Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects. Knop FK; Konings E; Timmers S; Schrauwen P; Holst JJ; Blaak EE Diabet Med; 2013 Oct; 30(10):1214-8. PubMed ID: 23663119 [TBL] [Abstract][Full Text] [Related]
26. Clinical pharmacology of DEAE-dextran for long-term administration (one year). Pupita F; Barone A Int J Clin Pharmacol Res; 1983; 3(4):287-93. PubMed ID: 6206004 [TBL] [Abstract][Full Text] [Related]
27. Gut regulatory peptides and pancreatic beta-cell response to nutritional stimuli in the elderly. Arnalich F; Hernanz A; Arribas JR; Codoceo R; Grande C; Vazquez JJ J Med; 1990; 21(6):323-30. PubMed ID: 1982670 [TBL] [Abstract][Full Text] [Related]
29. Cholinergic inhibition of meal stimulated plasma neurotensin like immunoreactivity in man. Fletcher DR; Shulkes A; Bladin PH; Booth D; Hardy KJ Life Sci; 1983 Aug; 33(9):863-9. PubMed ID: 6888194 [TBL] [Abstract][Full Text] [Related]
30. Effects of physical training on insulin, connecting peptide (C-peptide), gastric inhibitory polypeptide (GIP) and pancreatic polypeptide (PP) levels in obese subjects. Krotkiewski M; Björntorp P; Holm G; Marks V; Morgan L; Smith U; Feurle GE Int J Obes; 1984; 8(3):193-9. PubMed ID: 6378815 [TBL] [Abstract][Full Text] [Related]
31. The effect of a test meal on plasma vasoactive intestinal polypeptide (VIP), gastric inhibitory polypeptide (GIP), and secretin in man. Burhol PG; Waldum HL; Jorde R; Lygren I Scand J Gastroenterol; 1979; 14(8):939-43. PubMed ID: 531513 [TBL] [Abstract][Full Text] [Related]
32. Gut hormone responses in subjects with a permanent ileostomy. Kennedy HJ; Sarson DL; Bloom SR; Truelove SC Digestion; 1982; 24(2):133-6. PubMed ID: 7128957 [TBL] [Abstract][Full Text] [Related]
33. Effects of consumption of main and side dishes with white rice on postprandial glucose, insulin, glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 responses in healthy Japanese men. Kameyama N; Maruyama C; Matsui S; Araki R; Yamada Y; Maruyama T Br J Nutr; 2014 May; 111(9):1632-40. PubMed ID: 24507870 [TBL] [Abstract][Full Text] [Related]
35. The effect of somatostatin on fasting and postprandial plasma GIP, serum insulin, and blood glucose in man. Jorde R; Waldum HL; Burhol PG; Lygren I; Schulz TB; Florholmen J; Jenssen TG Scand J Gastroenterol; 1981; 16(1):113-9. PubMed ID: 6112787 [TBL] [Abstract][Full Text] [Related]
36. Effect of single dose of omeprazole on the gastrointestinal peptide response to food. Allen JM; Adrian TE; Webster J; Howe A; Bloom SR Hepatogastroenterology; 1984 Feb; 31(1):44-6. PubMed ID: 6365714 [TBL] [Abstract][Full Text] [Related]
37. Effect of diethylaminoethyl-dextran on colony formation of human tumor cells in semisolid suspension cultures. Hug V; Spitzer G; Drewinko B; Blumenschein GR Cancer Res; 1983 Jan; 43(1):210-3. PubMed ID: 6182989 [TBL] [Abstract][Full Text] [Related]
39. [Intestinal sequestrants: modern aspects of the use of diethylaminoethyl-dextran in the therapy of obesity]. Di Luigi L; Dal Lago A; Vita F; Isidori A Clin Ter; 1986 Apr; 117(1):37-43. PubMed ID: 2424662 [No Abstract] [Full Text] [Related]
40. [Effects of the acute administration of a new drug on base values and after stimulation of blood insulin and blood sugar in obese children]. Bartolotta E; Maurizi M; Stronati P; Panfoli C Clin Ter; 1986 Dec; 119(5):395-402. PubMed ID: 2435447 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]